BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 10407712)

  • 1. The efficacy and safety of budesonide inhalation suspension: a nebulizable corticosteroid for persistent asthma in infants and young children.
    White MV; Cruz-Rivera M; Walton-Bowen K
    Fam Med; 1999 May; 31(5):337-45. PubMed ID: 10407712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma.
    Hansel TT; Benezet O; Kafé H; Ponitz HH; Cheung D; Engelstätter R; Barnes PJ
    Clin Ther; 2006 Jun; 28(6):906-20. PubMed ID: 16860173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H; Orozco S; Allen A
    Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study.
    Niphadkar P; Jagannath K; Joshi JM; Awad N; Boss H; Hellbardt S; Gadgil DA
    Clin Ther; 2005 Nov; 27(11):1752-63. PubMed ID: 16368446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids.
    D'Urzo A; Karpel JP; Busse WW; Boulet LP; Monahan ME; Lutsky B; Staudinger H
    Curr Med Res Opin; 2005 Aug; 21(8):1281-9. PubMed ID: 16083538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma.
    Kuna P; Creemers JP; Vondra V; Black PN; Lindqvist A; Nihlen U; Vogelmeier C
    Respir Med; 2006 Dec; 100(12):2151-9. PubMed ID: 16701989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma.
    Karpel JP; Busse WW; Noonan MJ; Monahan ME; Lutsky B; Staudinger H
    Ann Pharmacother; 2005 Dec; 39(12):1977-83. PubMed ID: 16264062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and safety of budesonide inhalation suspension nebulization by mesh nebulizer in Japanese infants and young children with bronchial asthma in 12-week, randomised, open study].
    Tezuka J; Motomura C; Ikei J; Ide K; Kando N; Goto M; Taba N; Hayashi D; Murakami Y; Moriyasu Y; Soebijanto K; Shibata R; Okada K; Okada H; Nishima S
    Arerugi; 2008 Aug; 57(8):1034-42. PubMed ID: 18781108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparable morning versus evening administration of once-daily mometasone furoate dry powder inhaler.
    Zetterström O; Dahl R; Lindqvist A; Olsson P
    Respir Med; 2008 Oct; 102(10):1406-11. PubMed ID: 18640826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
    Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
    J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of budesonide Clickhaler and Turbuhaler in adult asthma.
    Morice A; Das S; Ellis S;
    J Asthma; 2005 Oct; 42(8):697-703. PubMed ID: 16266962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma.
    Berger WE; Milgrom H; Chervinsky P; Noonan M; Weinstein SF; Lutsky BN; Staudinger H
    Ann Allergy Asthma Immunol; 2006 Nov; 97(5):672-80. PubMed ID: 17165278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of disease duration on dose-response of inhaled budesonide in asthma.
    Selroos O
    Respir Med; 2008 Jul; 102(7):1065-72. PubMed ID: 18387797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a nighttime sleep diary in asthmatic children.
    Yoshihara S; Kanno N; Fukuda H; Yamada Y; Fukuda N; Tsuchiya T; Arisaka O
    Pediatr Allergy Immunol; 2011 Nov; 22(7):667-70. PubMed ID: 21950678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once- vs twice-daily budesonide/formoterol in 6- to 15-year-old patients with stable asthma.
    Eid NS; Noonan MJ; Chipps B; Parasuraman B; Miller CJ; O'Brien CD
    Pediatrics; 2010 Sep; 126(3):e565-75. PubMed ID: 20713475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Budesonide in the treatment of mild asthma. A placebo-controlled multicenter study in general practice].
    Damsbo N
    Ugeskr Laeger; 1994 Oct; 156(43):6384-8. PubMed ID: 7810015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.